Up a level |
Zijlstra, Josee M, Follows, George, Casasnovas, Rene-Olivier, Vermaat, Joost SP, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, Choquet, Sylvain, Hill, Brian, Thieblemont, Catherine, Cavallo, Federica, Cruz, Fatima De la et al (show 20 more authors)
(2022)
The Association between Patient Characteristics and the Efficacy and Safety of Selinexor in Diffuse Large B-Cell Lymphoma in the SADAL Study.
CANCERS, 14 (3).
791-.
Gleeson, Mary, Peckitt, Clare, To, Ye Mong, Edwards, Laurice, Oates, Jacqueline, Wotherspoon, Andrew, Attygalle, Ayoma D, Zerizer, Imene, Sharma, Bhupinder, Chua, Sue et al (show 18 more authors)
(2018)
CHOP versus GEM-P in previously untreated patients with peripheral T-cell lymphoma (CHEMO-T): a phase 2, multicentre, randomised, open-label trial.
LANCET HAEMATOLOGY, 5 (5).
E190-E200.
Farahani, Mosavar, Rubbi, Carlos, Liu, Luning ORCID: 0000-0002-8884-4819, Slupsky, Joseph R ORCID: 0000-0002-7410-9004 and Kalakonda, Nagesh ORCID: 0000-0002-5300-1360
(2015)
CLL Exosomes Modulate the Transcriptome and Behaviour of Recipient Stromal Cells and Are Selectively Enriched in miR-202-3p.
PLOS ONE, 10 (10).
e0141429-.
Lim, Yeong Jer ORCID: 0000-0002-9022-2904, Khan, Umair, Karpha, Indrani, Ross, Andrew, Saif, Muhammad, Remberger, Mats, Kalakonda, Nagesh, Pettitt, Andrew R and Floisand, Yngvar
(2022)
COVID-19 outcomes in haematopoietic cell transplant recipients: A systematic review and meta-analysis.
EJHaem, 3 (3).
pp. 862-872.
Blocksidge, Jemma
Characterisation of lens epithelium derived growth factor isoforms in chronic lymphocytic leukemia: Studies and significance.
Doctor of Philosophy thesis, University of Liverpool.
Anderson, Richard A, Remedios, Rachel, Kirkwood, Amy A, Patrick, Pip, Stevens, Linsey, Clifton-Hadley, Laura, Roberts, Tom, Hatton, Chris, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, Milligan, Don W et al (show 4 more authors)
(2018)
Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial.
The Lancet. Oncology, 19 (10).
pp. 1328-1337.
Mondru, Anil Kumar
(2018)
EFFECT OF IMMUNOMODULATORY AGENTS ON CRITICAL PATHWAYS IN CHRONIC LYMPHOCYTIC LEUKAEMIA.
Doctor of Philosophy thesis, University of Liverpool.
Bhogal, Talvinder ORCID: 0000-0003-3297-9957, Khan, Umair T ORCID: 0000-0002-9470-3481, Lee, Rebecca, Stockdale, Alexander ORCID: 0000-0002-5828-3328, Hesford, Christian, Potti-Dhananjaya, Vaishnav, Jathanna, Avith, Rahman, Shaun, Tivey, Ann, Shotton, Rohan et al (show 13 more authors)
(2021)
Haematological malignancy and nosocomial transmission are associated with an increased risk of death from COVID-19: results of a multi-center UK cohort.
Leukemia & lymphoma, 62 (7).
pp. 1-16.
Shah, Jatin, Shacham, Sharon, Kauffman, Michael, Daniele, Patrick, Tomaras, Dimitrios, Tremblay, Gabriel, Casasnovas, Rene-Olivier, Maerevoet, Marie, Zijlstra, Josee, Follows, George et al (show 26 more authors)
(2021)
Health-related quality of life and utility outcomes with selinexor in relapsed/refractory diffuse large B-cell lymphoma.
FUTURE ONCOLOGY, 17 (11).
pp. 1295-1310.
Linley, Adam J ORCID: 0000-0002-8176-5560, Karydis, Laura I, Mondru, Anil K, D'Avola, Annalisa, Al Shmrany, Humood, Cicconi, Silvia, Griffin, Rebecca, Forconi, Francesco, Pettitt, Andrew R, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360 et al (show 7 more authors)
(2021)
Kinobead Profiling Reveals Reprogramming of BCR Signaling in Response to Therapy within Primary CLL Cells.
CLINICAL CANCER RESEARCH, 27 (20).
pp. 5647-5659.
Till, Kathleen J ORCID: 0000-0002-3172-5771, Allen, John C, Talab, Fatima, Lin, Ke, Allsup, David, Cawkwell, Lynn, Bentley, Alison, Ringshausen, Ingo, Duckworth, Andrew D, Pettitt, Andrew R et al (show 2 more authors)
(2017)
Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome.
SCIENTIFIC REPORTS, 7 (1).
16784-.
Pettitt, Andrew R, Jackson, Richard, Cicconi, Silvia ORCID: 0000-0001-5507-6203, Polydoros, Fotis, Yap, Christina, Dodd, James, Bickerstaff, Matthew, Stackpoole, Michael, Khan, Umair T ORCID: 0000-0002-9470-3481, Carruthers, Stacey et al (show 16 more authors)
(2020)
Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukemia: final results of the NCRI CLL210 trial.
HAEMATOLOGICA, 105 (12).
pp. 2868-2871.
Duell, Johannes, Maddocks, Kami J, Gonzalez-Barca, Eva, Jurczak, Wojciech, Liberati, Anna Marina, de Vos, Sven, Nagy, Zsolt, Obr, Ales, Gaidano, Gianluca, Abrisqueta, Pau et al (show 11 more authors)
(2021)
Long-term outcomes from the phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma.
, Italy.
Hay, Jodie, Tarafdar, Anuradha, Holroyd, Ailsa K, Moka, Hothri A, Dunn, Karen M, Alshayeb, Alzahra, Lloyd, Bryony H, Cassels, Jennifer, Malik, Natasha, Khan, Ashfia F et al (show 6 more authors)
(2022)
PKCβ Facilitates Leukemogenesis in Chronic Lymphocytic Leukaemia by Promoting Constitutive BCR-Mediated Signalling.
CANCERS, 14 (23).
6006-.
Atherton, Kirsten, Young, Bridget ORCID: 0000-0001-6041-9901, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360 and Salmon, Peter ORCID: 0000-0001-6450-5209
(2018)
Perspectives of patients with haematological cancer on how clinicians meet their information needs: "Managing" information versus "giving" it.
PSYCHO-ONCOLOGY, 27 (07).
pp. 1719-1726.
Khan, Umair Tahir ORCID: 0000-0002-9470-3481, Kelly, Michael, Dodd, James, Fergiani, Sammy, Hammer, Barbara, Smith, Jeffrey, Arumainathan, Arvind, Atherton, Mark, Carter, Anthony, Racu-Amoasii, Igor et al (show 3 more authors)
(2021)
Role of MYC and BCL2 expression in a cohort of 43 patients with DLBCL: a retrospective study.
JOURNAL OF CLINICAL PATHOLOGY, 74 (12).
pp. 816-818.
Maerevoet, Marie, Zijlstra, Josee M, Follows, George, Casasnovas, Rene-Olivier, Vermaat, JSP, Kalakonda, Nagesh ORCID: 0000-0002-5300-1360, Goy, Andre, Choquet, Sylvain, Van den Neste, Eric, Hill, Brian et al (show 24 more authors)
(2021)
Survival among patients with relapsed/refractory diffuse large B cell lymphoma treated with single-agent selinexor in the SADAL study.
JOURNAL OF HEMATOLOGY & ONCOLOGY, 14 (1).
111-.
Alhmoud, JF
(2019)
THE UTILITY OF A FACS BASED MICRONUCLEUS ASSAY FOR ASSESSMENT OF DNA DAMAGE.
Doctor of Philosophy thesis, University of Liverpool.